StockData
Molecular Partners AG logo

Molecular Partners AG (MOLN) stock

MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.86+0.16 (+5.98%)

Close on Nov 17, 2026Market cap $115.47MP/E –Yield –

Molecular Partners pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Molecular Partners's pe ratio was 1.1× on Feb 29, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Feb 29, 20241.1×+0.1
2023Dec 29, 20231.0×–

More Molecular Partners figures

See a number that looks wrong?